Li, Q.; Wang, J.; Cheng, Y.; Hu, A.; Li, D.; Wang, X.; Guo, Y.; Zhou, Y.; Chen, G.; Bao, B.;
et al. Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study. J. Clin. Med. 2023, 12, 754.
https://doi.org/10.3390/jcm12030754
AMA Style
Li Q, Wang J, Cheng Y, Hu A, Li D, Wang X, Guo Y, Zhou Y, Chen G, Bao B,
et al. Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study. Journal of Clinical Medicine. 2023; 12(3):754.
https://doi.org/10.3390/jcm12030754
Chicago/Turabian Style
Li, Qilan, Jianqun Wang, Yang Cheng, Anpei Hu, Dan Li, Xiaojing Wang, Yanhua Guo, Yi Zhou, Guo Chen, Banghe Bao,
and et al. 2023. "Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study" Journal of Clinical Medicine 12, no. 3: 754.
https://doi.org/10.3390/jcm12030754
APA Style
Li, Q., Wang, J., Cheng, Y., Hu, A., Li, D., Wang, X., Guo, Y., Zhou, Y., Chen, G., Bao, B., Gao, H., Song, J., Du, X., Zheng, L., & Tong, Q.
(2023). Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study. Journal of Clinical Medicine, 12(3), 754.
https://doi.org/10.3390/jcm12030754